Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Defender Capital LLC.

Defender Capital LLC. lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 7.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 39,085 shares of the biotechnology company’s stock after selling 3,374 shares during the quarter. Axon Enterprise makes up approximately 8.5% of Defender Capital LLC.’s portfolio, making the stock its 5th largest holding. Defender Capital LLC. owned 0.05% of Axon Enterprise worth $23,229,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the business. Asset Dedication LLC raised its stake in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares during the period. Insigneo Advisory Services LLC raised its stake in shares of Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after purchasing an additional 22 shares during the last quarter. Menard Financial Group LLC boosted its position in Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after purchasing an additional 24 shares during the last quarter. PFG Investments LLC grew its stake in shares of Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after acquiring an additional 25 shares during the period. Finally, Gladstone Institutional Advisory LLC grew its stake in Axon Enterprise by 1.6% during the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after acquiring an additional 26 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have weighed in on AXON shares. Needham & Company LLC raised their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Northland Securities lifted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. JMP Securities raised their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird upped their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $524.85.

Insiders Place Their Bets

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 50,545 shares of company stock worth $30,721,337. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Up 0.4 %

NASDAQ:AXON opened at $639.97 on Thursday. The firm has a market cap of $48.80 billion, a P/E ratio of 165.37, a PEG ratio of 6.09 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $247.04 and a 12-month high of $698.67. The stock’s 50 day simple moving average is $618.90 and its 200-day simple moving average is $477.78.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.